Aim To evaluate the short-term efficacy and safety of monthly intravitreal injections of ranibizumab in patients with polypoidal choroidal vasculopathy (PCV) and active exudation or haemorrhage.Methods A prospective, open-label trial of monthly intravitreal ranibizumab (0.5 mg) injections for PCV in...
No comments yet
Be the first to share your thoughts!